Faecal microbiota transplantation for IBS: still a long way to go

Affiliations

Comment

Paul Moayyedi. Lancet Gastroenterol Hepatol. 2019 Sep.

. 2019 Sep;4(9):656-657.

doi: 10.1016/S2468-1253(19)30226-2. Epub 2019 Jul 17.

¹ Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: moayyep@mcmaster.ca.

No abstract available

Comment on

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ. Aroniadis OC, et al. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):675-685. doi: 10.1016/S2468-1253(19)30198-0. Epub 2019 Jul 17. Lancet Gastroenterol Hepatol. 2019. PMID: 31326345 Clinical Trial.